Literature DB >> 8943812

Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation.

C A Cooper1, V J Bubb, N Smithson, R L Carter, S Gledhill, D Lamb, A H Wyllie, F A Carey.   

Abstract

Four genetic polymorphisms in the APC and MCC genes at chromosome 5q21 were analysed for loss of heterozygosity (LOH) in 97 primary squamous carcinomas and adenocarcinomas of the lung. LOH was identified in at least two polymorphic loci in 41 percent of informative cases. There was no significant difference in the frequency of LOH between squamous carcinomas and adenocarcinomas. Within the adenocarcinoma group, however, LOH appeared to be more common in tumours having a bronchial origin (5/9; 56 per cent) than in parenchymal adenocarcinoma (6/21; 29 per cent). All 32 tumours showing LOH at one or more polymorphic sites were examined for mutations in the mutation cluster region (MCR) of APC by single-strand conformational polymorphism (SSCP) analysis. Mutations were not detected in any of these cases. We therefore propose that it is likely that a tumour suppressor gene on 5q other than APC is involved in the pathogenesis of lung cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8943812     DOI: 10.1002/(SICI)1096-9896(199609)180:1<33::AID-PATH642>3.0.CO;2-Y

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma.

Authors:  P Mendes-da-Silva; A Moreira; J Duro-da-Costa; D Matias; C Monteiro
Journal:  Mol Pathol       Date:  2000-08

3.  Report on mutation in exon 15 of the APC gene in a case of brain metastasis.

Authors:  Nives Pećina-Slaus; Zeljka Majić; Vesna Musani; Martina Zeljko; Hrvoje Cupić
Journal:  J Neurooncol       Date:  2009-08-27       Impact factor: 4.130

4.  Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.

Authors:  Satoshi Ikeda; Masahiko Fujimori; Satoshi Shibata; Masazumi Okajima; Yasuyo Ishizaki; Takeshi Kurihara; Yoshihiro Miyata; Masahiko Iseki; Yosuke Shimizu; Noriaki Tokumoto; Shinji Ozaki; Toshimasa Asahara
Journal:  BMC Cancer       Date:  2006-02-02       Impact factor: 4.430

5.  Combined analysis with copy number variation identifies risk loci in lung cancer.

Authors:  Xinlei Li; Xianfeng Chen; Guohong Hu; Yang Liu; Zhenguo Zhang; Ping Wang; You Zhou; Xianfu Yi; Jie Zhang; Yufei Zhu; Zejun Wei; Fei Yuan; Guoping Zhao; Jun Zhu; Landian Hu; Xiangyin Kong
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

6.  Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin.

Authors:  Anja Kafka; Davor Tomas; Vili Beroš; Hrvoje Ivan Pećina; Martina Zeljko; Nives Pećina-Šlaus
Journal:  Int J Mol Sci       Date:  2014-06-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.